SAN FRANCISCO — Oura, the Finnish wearable technology company, announced Thursday the launch of its smallest smart ring to date, the Oura Ring 5, which is 40% smaller than its predecessor while maintaining the same advanced sensing capabilities and accuracy.
Oura Ring 5
The new device, set to begin shipping on June 4, represents a significant step forward in discreet wearable design. It will be priced at $399 for standard finishes and $499 for premium options such as gold and brushed silver. A new portable charging case will be available separately for $99.
Oura CEO Tom Hale emphasized the design breakthrough in a statement. “By reimagining Oura Ring 5 to be smaller, easier to wear, and pairing it with our most advanced software yet, we’re making it possible for many more people to wear Oura every day — and to benefit from the personalized, predictive health insights that come with it,” Hale said.
The company has positioned the Ring 5 as part of its broader push into preventative and predictive healthcare. Alongside the hardware launch, Oura is introducing several new software features that will also be available to users of its Generation 3 and 4 rings.
New Health Monitoring Capabilities
The most notable addition is an expanded proactive health tracking system called Health Radar. This feature continuously monitors key biometric signals including body temperature, respiratory rate, and heart rate variability. It alerts users to significant deviations that may indicate strain, illness, or recovery needs.
Advertisement
Additional capabilities include tracking blood pressure patterns during sleep to identify potential cardiovascular risks and analyzing nighttime breathing disturbances. These enhancements aim to provide users with earlier warnings about health issues before symptoms become noticeable.
Oura is also partnering with on-demand healthcare platform Counsel Health to offer AI-enabled care directly within the Oura app. Subscribers in 43 U.S. states will be able to ask health-related questions, receive personalized advice, and connect with licensed providers.
For users taking GLP-1 weight-loss medications, the company added specialized insights to help track dosing schedules, weight changes, and related biometric data. The ring will also feature improved real-time activity tracking for exercises such as running and cycling.
Company Growth and Market Position
Oura has experienced remarkable expansion in recent years. The company reported selling more than 5.5 million rings since its launch, up from 2.5 million in June 2024. It is on track to surpass five million paid members this quarter, representing a fourfold increase over the past two years. Revenue has grown at a similar pace.
Advertisement
Last October, Oura raised $900 million in a Series E funding round, bringing its valuation to $11 billion. The company has raised more than $1.5 billion in total funding. Hale previously projected the company could reach nearly $2 billion in sales during 2026.
Oura has been recognized four times on the CNBC Disruptor 50 list, most recently ranking No. 14 in 2026. The company confidentially filed a draft IPO prospectus with the Securities and Exchange Commission last week, though it has not provided a specific timeline for going public.
Design and Technical Improvements
Despite its significantly smaller size, the Oura Ring 5 maintains the full suite of sensors found in previous models. The company achieved the size reduction through advanced engineering and component miniaturization without compromising battery life or data accuracy.
The sleeker profile addresses a common criticism of earlier generations — that the ring could feel bulky for some users, particularly those with smaller hands. Oura says the new design makes the device more comfortable for continuous 24/7 wear, potentially increasing user adherence and data quality.
Advertisement
The portable charging case provides a convenient solution for users who travel frequently or prefer not to remove the ring regularly. A single charge of the case can provide multiple top-ups for the ring.
Competitive Landscape
Oura faces increasing competition in the smart ring category. Samsung has entered the market with its Galaxy Ring, and several smaller startups are also developing similar devices. However, Oura maintains a strong lead in clinical validation and data accuracy, with multiple peer-reviewed studies supporting its sleep and recovery metrics.
The company’s focus on preventative health and integration with professional medical services differentiates it from purely consumer-oriented wearables. By combining hardware, software, and telehealth capabilities, Oura is positioning itself as a comprehensive health monitoring platform rather than just a fitness tracker.
Broader Implications for Wearable Technology
The launch of the Oura Ring 5 reflects a broader trend in consumer health technology toward smaller, less intrusive devices that provide clinical-grade insights. As consumers become more health-conscious following the COVID-19 pandemic, demand for continuous monitoring tools has grown significantly.
Advertisement
Industry analysts expect the global smart ring market to expand rapidly over the next five years. Oura’s emphasis on medical-grade features and partnerships with healthcare providers could help establish the category as a legitimate tool for preventative care rather than just lifestyle tracking.
The company’s IPO preparations suggest confidence in its growth trajectory. If successful, an initial public offering would mark a significant milestone for the Finnish startup and could provide capital for further expansion into new markets and features.
User Reception and Future Plans
Early reactions from existing Oura users have been largely positive regarding the smaller design. Many have expressed excitement about the new health features, particularly the blood pressure and breathing pattern tracking.
Oura has indicated that additional features and integrations are planned for later in 2026. The company continues to invest heavily in artificial intelligence to improve the accuracy and actionability of its insights.
Advertisement
As the wearable technology sector matures, Oura’s latest release demonstrates the company’s commitment to balancing elegant design with sophisticated health monitoring capabilities. The Ring 5 could help bring continuous biometric tracking to a wider audience while reinforcing Oura’s position as a leader in the emerging preventative healthcare space.
The Oura Ring 5 will be available for pre-order starting immediately, with deliveries beginning June 4. Existing members will receive access to the new software features through an automatic update.
Dear Reader,I am a Senior Derivatives Expert with over 10 years of experience in the field of Asset Management, specializing in equity analysis and research, macroeconomics, and risk-managed portfolio construction. My professional background covers both institutional and private client asset management, where I have advised on and implemented multi-asset strategies, but highly focusing on equities and derivatives.As you might be as well, I am a stock market enthusiast. My core passion lies in understanding how macro trends influence both asset prices and investor behavior. I closely follow EU and US central bank policies, sector rotation, and sentiment dynamics, and construct actionable investment strategies.BA in Financial Economics, MA in Financial Markets. In the past decade, I have navigated through various market conditions, and this was my PhD.One of the essential goals of writing on Seeking Alpha is to share insights with colleagues, fellow investors, exchange ideas, and become slightly better than yesterday. I contribute to the idea that investing should be accessible, inspiring, and empowering. It might sound like a cliche, I know, but in the end it’s highly valuable – so let’s help each other build confidence in long-term investing. The analysis and opinions shared in my articles and comments are for informational purposes only and should not be considered financial advice. Please do your own research before making any investment decisions.Thank you and have a lovely day!Best regards
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in ZETA over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Resources Minister Madeleine King used a visit to Perth to reaffirm her support for strike action at BHP’s Port Hedland operations, which could cost the miner up to $120 million per day.
The Hawkstone brewery co-founder confirmed the news on his hit television show Clarkson’s Farm
Hannah Baker South West Business Editor and Jessica Coates Press Association
08:12, 17 Jun 2026Updated 08:14, 17 Jun 2026
Jeremy Clarkson with a Hawkstone beer(Image: Handout)
Jeremy Clarkson has announced he has been diagnosed with cancer. The former Top Gear presenter and Hawkstone brewery co-founder revealed the news in the latest episodes of season five of Clarkson’s Farm.
He disclosed that the disease was “aggressive” but had been caught at an early stage.
Advertisement
“I’ve got cancer,” Clarkson told farm manager Kaleb Cooper and farmhand Charlie Ireland during discussions about harvest planning.
The TV presenter-turned-farmer said he anticipated being “fine” but would be out of action “for a while”.
Speaking from a hospital bed at the close of the season finale, Clarkson explained he had encountered complications throughout his treatment.
“We started season five with me in a hospital bed and here we are at the end of season five and I’m back in a hospital bed,” he said.
Advertisement
The 66-year-old reflected on the future of the show.
“What I wanted to say was if this is all successful, I’ll see you for season six, and if it isn’t, I won’t,” he said. “Take care, everyone.”
The revelation comes nearly two years after Clarkson underwent a cardiac procedure.
Clarkson’s Farm follows the veteran television presenter and his team as they tackle the trials and tribulations of running Diddly Squat Farm near Chipping Norton, Oxfordshire.
Advertisement
Since taking on the running of his farm in 2019 and subsequently launching his hugely popular reality series, Clarkson has become a prominent champion of British farmers, attending a protest in London against the Government’s plans to impose inheritance tax on farmland in November 2024.
The programme’s sixth series is scheduled to broadcast in 2027.
Clarkson has also found success with his brewery business. Earlier this month, Gloucestershire’s Hawkstone was named the fastest-growing private business in the South West of England by the Sunday Times.
Hawkstone topped the Sunday Times 100 regional list after making £44.9m in sales in the year to March – a staggering 128.19 per cent average annual growth in the last three years.
You must be logged in to post a comment Login